| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD008143.PUB4 |
| P8608 | Fatcat ID | release_wlngdyrlpfekbi6u4kmtpbjlpe |
| P3181 | OpenCitations bibliographic resource ID | 5059219 |
| P698 | PubMed publication ID | 26222248 |
| P50 | author | Bianca Hemmingsen | Q114426371 |
| Thomas Almdal | Q114398833 | ||
| Christian Gluud | Q26265142 | ||
| Jørn Wetterslev | Q28037207 | ||
| P2093 | author name string | Allan Vaag | |
| Søren S Lund | |||
| P2860 | cites work | Economic costs of diabetes in the U.S. in 2012 | Q22241287 |
| Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults | Q22250879 | ||
| Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes | Q22250887 | ||
| Sulphonylurea monotherapy for patients with type 2 diabetes mellitus | Q24197884 | ||
| Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus | Q24236456 | ||
| Rosiglitazone for type 2 diabetes mellitus | Q24243875 | ||
| Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus | Q24245192 | ||
| Metformin monotherapy for type 2 diabetes mellitus | Q24246552 | ||
| Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis | Q24289436 | ||
| Sequential methods for random-effects meta-analysis | Q24289522 | ||
| CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials | Q24614759 | ||
| Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials | Q24628988 | ||
| What is meant by intention to treat analysis? Survey of published randomised controlled trials | Q24647858 | ||
| Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study | Q24652963 | ||
| Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study | Q24653790 | ||
| Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study | Q24654974 | ||
| Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes | Q27004274 | ||
| Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials | Q27860735 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 | ||
| Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial | Q28165854 | ||
| Randomised controlled trial of structured personal care of type 2 diabetes mellitus | Q28362638 | ||
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
| Effects of intensified metabolic control on CNS function in type 2 diabetes | Q38371699 | ||
| Evaluation of a pharmaceutical care model on diabetes management | Q39431403 | ||
| Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections | Q39474763 | ||
| Effects of motivational interviewing intervention on self-management, psychological and glycemic outcomes in type 2 diabetes: a randomized controlled trial | Q39668936 | ||
| Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study. | Q39885755 | ||
| 3-year follow-up of clinical and behavioral improvements following a multifaceted diabetes care intervention: results of a randomized controlled trial | Q39895364 | ||
| Effect of An Educational Inpatient Diabetes Management Program on Medical Resident Knowledge and Measures of Glycemic Control: A Randomized Controlled Trial | Q40027430 | ||
| Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment | Q40901830 | ||
| The Minnesota diabetes complications clinical trial the first three years | Q41557104 | ||
| Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study | Q41776334 | ||
| A Single Blinded Randomized Controlled Study of the Effect of Conventional Oral Hypoglycemic Agents Versus Intensive Short-Term Insulin Therapy on Pure Tone Audiometry in Type II Diabetes Mellitus | Q41973986 | ||
| Effect of short‐term intensive insulin therapy on quality of life in type 2 diabetes | Q42477142 | ||
| Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia | Q42507791 | ||
| Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial | Q42620871 | ||
| Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study | Q42624054 | ||
| Effects of Moderate Intensity Glycemic Control After Cardiac Surgery | Q42795401 | ||
| Severe hypoglycemia and risks of vascular events and death | Q42868535 | ||
| Insiders criticise FDA's decision not to withdraw rosiglitazone | Q42873506 | ||
| Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes | Q43025106 | ||
| Improving glycaemic control self-efficacy and glycaemic control behaviour in Chinese patients with type 2 diabetes mellitus: randomised controlled trial | Q43054860 | ||
| Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis | Q43080233 | ||
| Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials | Q43180125 | ||
| Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study | Q43181601 | ||
| The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis | Q43264110 | ||
| The response to short-term intensive insulin therapy in type 2 diabetes | Q43279191 | ||
| Clinical inertia in general practice: widespread and related to the outcome of diabetes care | Q43281199 | ||
| Cumulating evidence from randomized trials: Utilizing sequential monitoring boundaries for cumulative meta-analysis | Q43471039 | ||
| Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51). | Q43585439 | ||
| Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes. | Q43641813 | ||
| Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? | Q43707230 | ||
| Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report. | Q43711367 | ||
| The effects of intensive glycaemic control on body composition in patients with type 2 diabetes. | Q43923302 | ||
| Intensive insulin treatment reduces transient ischaemic episodes during acute coronary events in diabetic patients | Q44197604 | ||
| Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes | Q44295713 | ||
| Effect of intravenous insulin administration on left ventricular performance during non-ST-elevation acute coronary events in patients with diabetes mellitus. | Q44439751 | ||
| Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial | Q44459441 | ||
| Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity | Q44642265 | ||
| Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention | Q44722282 | ||
| Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes | Q44802298 | ||
| The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. | Q44812728 | ||
| Short-term intensive insulin therapy in newly diagnosed type 2 diabetes | Q44865579 | ||
| Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators | Q45334489 | ||
| Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes | Q45335749 | ||
| Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. | Q45919268 | ||
| Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis. | Q45954011 | ||
| Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. | Q46019125 | ||
| An intensive nurse-led, multi-interventional clinic is more successful in achieving vascular risk reduction targets than standard diabetes care | Q46050837 | ||
| Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). | Q46440924 | ||
| Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. | Q46576386 | ||
| Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus | Q46579586 | ||
| Treatment intensification in patients with type 2 diabetes | Q46627826 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation | Q29547453 | ||
| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes | Q29547541 | ||
| Effects of intensive glucose lowering in type 2 diabetes | Q29547736 | ||
| 10-year follow-up of intensive glucose control in type 2 diabetes | Q29615973 | ||
| Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
| Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses | Q29619185 | ||
| Glucose control and vascular complications in veterans with type 2 diabetes | Q29619213 | ||
| Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? | Q29619328 | ||
| Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Q29619886 | ||
| Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial | Q30443934 | ||
| Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. | Q30759070 | ||
| What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data | Q30926358 | ||
| Uncertainty method improved on best-worst case analysis in a binary meta-analysis | Q33214758 | ||
| Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses | Q33372680 | ||
| A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44) | Q33420745 | ||
| Estimating required information size by quantifying diversity in random-effects model meta-analyses. | Q33521365 | ||
| Event rates, hospital utilization, and costs associated with major complications of diabetes: a multicountry comparative analysis | Q33534641 | ||
| Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT) | Q33556796 | ||
| The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study | Q33579765 | ||
| Effects of medical therapies on retinopathy progression in type 2 diabetes | Q33620031 | ||
| Design and Organization of the Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT) Trial: a factorial trial evaluating the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity | Q33621941 | ||
| The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and [...] | Q33696402 | ||
| Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial | Q33751427 | ||
| No negative effects of a multi-factorial, intensified treatment on self-reported health status, treatment satisfaction, and diabetes-related distress in screen-detected type 2 diabetes patients. The ADDITION-Netherlands study | Q33780967 | ||
| Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes | Q33851861 | ||
| Effects of combination lipid therapy in type 2 diabetes mellitus | Q33889260 | ||
| MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial | Q33966645 | ||
| Effects of intensive blood-pressure control in type 2 diabetes mellitus | Q34008161 | ||
| Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial | Q34008233 | ||
| Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality | Q34127761 | ||
| Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial | Q34229170 | ||
| Resurrections in Toronto: the emergence of insulin | Q34467422 | ||
| Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction | Q34486703 | ||
| The influence of glucose-lowering therapies on cancer risk in type 2 diabetes | Q34609508 | ||
| Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis | Q34686103 | ||
| Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial | Q34718335 | ||
| Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study | Q34720231 | ||
| Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials | Q34982751 | ||
| Intensive glucose control and macrovascular outcomes in type 2 diabetes. | Q34995674 | ||
| Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities | Q34996991 | ||
| Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial | Q35106580 | ||
| Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission | Q35123342 | ||
| Observation on Renal Outcomes in the Veterans Affairs Diabetes Trial | Q35179862 | ||
| Rapid improvement of glycemic control in type 2 diabetes using weekly intensive multifactorial interventions: structured glucose monitoring, patient education, and adjustment of therapy-a randomized controlled trial | Q35239520 | ||
| Piloting a novel algorithm for glucose control in the coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial | Q35620235 | ||
| Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus | Q35894298 | ||
| Insulin treatment and cardiovascular disease; friend or foe? A point of view. | Q36014899 | ||
| Bariatric surgery versus intensive medical therapy in obese patients with diabetes | Q36025669 | ||
| Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia | Q36108419 | ||
| Bias in clinical intervention research. | Q36380552 | ||
| Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge. | Q36445913 | ||
| Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials | Q36529261 | ||
| The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews | Q36721160 | ||
| Hepatology may have problems with putative surrogate outcome measures | Q36742914 | ||
| Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study | Q36807446 | ||
| Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial | Q36974117 | ||
| The barrier of hypoglycemia in diabetes | Q36975419 | ||
| Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial | Q37105140 | ||
| Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses | Q37138228 | ||
| Comparison of three protocols for tight glycemic control in cardiac surgery patients | Q37163690 | ||
| Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial | Q37400845 | ||
| Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials | Q37406894 | ||
| Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus | Q37435643 | ||
| Systematic review: glucose control and cardiovascular disease in type 2 diabetes | Q37557021 | ||
| Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control | Q37621774 | ||
| The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews | Q37692721 | ||
| The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis | Q37728777 | ||
| A Structured Self-Monitoring of Blood Glucose Approach in Type 2 Diabetes Encourages More Frequent, Intensive, and Effective Physician Interventions: Results from the STeP Study | Q37875107 | ||
| One-Year Efficacy and Safety of the Telehealth System in Poorly Controlled Type 2 Diabetic Patients Receiving Insulin Therapy | Q37924811 | ||
| Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies | Q38044510 | ||
| Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a KDOQI Clinical Practice Guideline | Q38045530 | ||
| External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? | Q38052932 | ||
| Effect of a multifactorial intervention on mortality in type 2 diabetes | Q46767642 | ||
| The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. | Q46835037 | ||
| Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial | Q48592706 | ||
| Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial | Q49080909 | ||
| Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). | Q50110246 | ||
| Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study | Q50659787 | ||
| Long-term multiple risk factor interventions in Japanese elderly diabetic patients: the Japanese Elderly Diabetes Intervention Trial--study design, baseline characteristics and effects of intervention | Q50760089 | ||
| Randomized study of two different target levels of glycemic control within the acceptable range in type 2 diabetes. Effects on well-being at 1 year | Q51093284 | ||
| Factors associated with progression of diabetic nephropathy in Japanese elderly patients with type 2 diabetes: Sub‐analysis of the Japanese Elderly Diabetes Intervention Trial | Q51343635 | ||
| Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study | Q51361683 | ||
| Can a protocol for glycaemic control improve type 2 diabetes outcomes after gastric bypass? | Q51365817 | ||
| Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a r | Q51366172 | ||
| Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study. | Q51371652 | ||
| Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty. | Q51496269 | ||
| Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study | Q51559365 | ||
| Validation of the DeLiT Trial intravenous insulin infusion algorithm for intraoperative glucose control in noncardiac surgery: a randomized controlled trial | Q51566965 | ||
| Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM) | Q51570200 | ||
| Methods for combining randomized clinical trials: strengths and limitations | Q52599212 | ||
| Overcoming the limitations of current meta-analysis of randomised controlled trials | Q52900034 | ||
| Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project | Q53566418 | ||
| The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction | Q53727713 | ||
| A Coefficient of Agreement for Nominal Scales | Q57167717 | ||
| Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial | Q57274347 | ||
| Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Q57412648 | ||
| Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods | Q58040103 | ||
| Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: The Microalbuminuria Education and Medication Optimisation (MEMO) study | Q58053366 | ||
| Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials | Q58393670 | ||
| Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group | Q58678827 | ||
| Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden | Q61852798 | ||
| Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group | Q66972631 | ||
| Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM) | Q67484783 | ||
| Determination of the glycemic threshold for the regression or prevention of diabetic microangiopathies, and the insulin injection regimen to establish strict glycemic control in NIDDM | Q67869411 | ||
| Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-up | Q71338245 | ||
| Induced basal normoglycemia and altered platelet aggregation in non-insulin-dependent diabetes | Q71638766 | ||
| Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction | Q71703483 | ||
| Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study | Q71829392 | ||
| Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year | Q72351090 | ||
| The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients | Q73668843 | ||
| Is intensive glycemic control worth the expense? | Q73725746 | ||
| Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study | Q74464563 | ||
| Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures | Q77304168 | ||
| Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study | Q77761919 | ||
| Inflammatory and oxidative stress markers after intravenous insulin in percutaneous coronary intervention with stent in type 2 diabetes mellitus: a randomized controlled trial | Q82488411 | ||
| Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study | Q83497336 | ||
| Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo") | Q83541230 | ||
| Diabetes Care Protocol: effects on patient-important outcomes. A cluster randomized, non-inferiority trial in primary care | Q84382053 | ||
| The Effects of a Supplemental, Theory-Based Physical Activity Counseling Intervention for Adults With Type 2 Diabetes | Q84875270 | ||
| Intensive versus conventional insulin therapy in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial | Q85106638 | ||
| P921 | main subject | type 2 diabetes | Q3025883 |
| P577 | publication date | 2015-07-29 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus |
| Q49535437 | Chinese herbal medicine TangBi Formula treatment of patients with type 2 diabetic distal symmetric polyneuropathy disease: study protocol for a randomized controlled trial |
| Q88315306 | DIRECT COSTS OF TYPE 2 DIABETES: A BRAZILIAN COST-OF-ILLNESS STUDY |
| Q36267548 | Glucose and fatty acid metabolism in infarcted heart from streptozotocin-induced diabetic rats after 2 weeks of tissue remodeling |
| Q36417868 | Insulin Therapy and Cancer in Type 2 Diabetes |
| Q34083400 | Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials |
| Q40325268 | Investigation on hypoglycemic effects of ethanol extract of Alpinia nigra (Gaertn.) in animal model. |
| Q40615169 | Platelet-rich plasma, bilayered acellular matrix grafting and negative pressure wound therapy in diabetic foot infection |
| Q64228177 | The benefits of non-surgical weight management on weight and glycaemic control in people with complex type 2 diabetes: A primary care service evaluation of clinical outcomes at 12 months |
Search more.